Shandong Pharmaceutical Glass Co., Ltd.SSE: 600529

Announcement on Progress in Using Partial Idle Raised Funds to Purchase Structured Deposits

· Issued by Shandong Pharmaceutical Glass Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 7 pages · Chinese

Summary by 6ix AI

Shandong Pharmaceutical Glass Co., Ltd. has announced progress regarding the use of idle raised funds to purchase structured deposits. The company has authorized the use of a specific amount of idle funds for this investment, which aims to enhance the efficiency of fund utilization while ensuring the safety of the funds. The investment is expected to generate returns without affecting the company's ongoing projects funded by the raised capital. The filing includes risk assessments related to market fluctuations that could impact the investment's performance.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Progress in Using Partial Idle Raised Funds to Purchase Structured Deposits

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shandong Pharmaceutical Glass Co., Ltd. on 6ix

Earlier from Shandong Pharmaceutical Glass

Later from Shandong Pharmaceutical Glass

All Shandong Pharmaceutical Glass news releases